Please login to the form below
consumer health unit
This page shows the latest consumer health unit news and features for those working in and with pharma, biotech and healthcare.
Takeda to sell Japan consumer health unit for $2.3bn
Deal helps to reduce debt accrued from Shire takeover. Takeda is on the verge of selling its consumer health unit in Japan for up to $2.3bn to Blackstone Group, an ... According to a statement from Takeda, Blackstone intends to develop the business
Latest news
-
Sanofi said to be looking at options for $30bn consumer health unit
Sanofi’s consumer health brands include allergy treatment Allegra, Rolaids antacids, IcyHot for muscle pain and the Dulcolax laxative range. ... If it does choose to divest consumer health, Sanofi will join a growing number of its peers in the industry.
-
Hudson named Brandicourt’s successor as Sanofi’s CEO
Olivier Brandicourt. Brandicourt presided over a restricting of Sanofi’s business, masterminding the exchange of its animal health business with Boehringer Ingelheim’s consumer health unit in a $25bn asset swap
-
Bayer axes 1,250 pharma jobs, with R&D taking the brunt
Bayer is also thinking of selling off some of its consumer health brands – notably Coppertone sun care and Dr Scholl foot care products – as well as its 60% stake in German ... The consumer health unit will lose around 1, 100 workers, with crop
-
Pfizer builds gap between pharma and consumer health units
Its consumer health division will become a standalone unit after lack of buyer interest. ... Pfizer’s efforts to find a buyer for its consumer health business have come to nothing, so it’s reorganising to make it easier to pursue other options for
-
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
Merck revealed it was considering a sale or partnership of its consumer health unit last year, marking a departure for the traditionally conservative, family-owned group, which for many years has ... Pfizer has also been trying to agree a sale for its
More from news
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma leaders to watch in 2020
The checklist of retooling initiatives include a deal to merge Pfizer’s off-patent drug business with generic drugmaker Mylan, combining consumer health assets with GlaxoSmithKline’s equivalent division into a ... Following through on that, Hudson
-
Having it all: Women in wealthy countries consider what makes them happy
A survey conducted by The Economist Intelligence Unit (EIU) on behalf of Merck Consumer Health, and presented in the recently released study Women's health and well-being: evolving definitions and ... The focus on health as a defining element of
-
Aiming high for women
A survey conducted by the Economist Intelligence Unit (EIU) on behalf of Merck Consumer Health, and presented in the recently released study Women's health and well-being: evolving definitions and ... There are good reasons for a focus on the broader
-
Sustainable solutions
While focusing on LifeSciences, Bayer was working hard to boost its standing in the consumer health space. ... In May 2014 it paid $14.2bn for Merck &Co's consumer health unit.
-
Preparing for growth in consumer healthcare
These marked a number of significant advances in the last century as the company expanded from a standard pharmacy to become a significant player in consumer health. ... Patient focus. Having led Merck's global allergy business unit Allergopharma and now
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Bayer appoints senior vice president for consumer health unit
Brenda Raphael joins from Pfizer, where she was general manager. Bayer has appointed Brenda Raphael as its new senior vice president and general manager of its therapeutic business unit of consumer ... Natalie Bartner, president of North America consumer
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
